Building ties in pharma industry 'just like courtship'

[By The Straits Times]

The Straits Times sat down with our CEO, Dr Gideon Ho, to find out how Histoindex Pte Ltd's Genesis®200 system is breaking new grounds in developing drugs for liver conditions, particularly non-alcoholic steatohepatitis (NASH).

Click here for the full story.


Our site uses cookies or similar technologies to recognise your repeated visits and preferences for us to deliver an optimal browsing experience. Please remember to read our privacy statement.

By clicking on "I Accept" or "X" to continue your browsing on this site, you consent to the use of the cookies. To find out how you can disable cookies on your device, please click here.

I Accept